ImmuPharma plc (IMM.L)
GBp 1.11
(0.68%)
GBp 1.11
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 118.35 Thousand | 126.66 Thousand | 77.92 Thousand | 81.28 Thousand |
| Cost of Revenue | 37.6 Thousand | 117.56 Thousand | - | - | - | - |
| Gross Profit | -37.6 Thousand | -117.56 Thousand | 118.35 Thousand | 126.66 Thousand | 77.92 Thousand | 81.28 Thousand |
| Operating Expenses | 3.06 Million | 3.02 Million | 5.27 Million | 5.71 Million | 6.35 Million | 8.16 Million |
| Selling, General and Administrative Expenses | 1.16 Million | 846.57 Thousand | 1.01 Million | 1.76 Million | 1.83 Million | 1.66 Million |
| Research and Development Expenses | 2.02 Million | 2.02 Million | 3.65 Million | 2.37 Million | 2.66 Million | 4.69 Million |
| Other Expenses | -119.88 Thousand | 159.87 Thousand | 616.42 Thousand | 1.57 Million | 1.86 Million | 1.8 Million |
| Cost and Expenses | 3.06 Million | 3.02 Million | 5.27 Million | 5.71 Million | 6.35 Million | 8.16 Million |
| Operating Income | -3.06 Million | -3.02 Million | -6.58 Million | -5.58 Million | -6.28 Million | -8.08 Million |
| Interest Expense | 1986.00 | 1.45 Million | 2.35 Million | 1.69 Million | 526.73 Thousand | 4783.00 |
| Income Tax Expense | -497.1 Thousand | -648.9 Thousand | -766.81 Thousand | -386.24 Thousand | -620.77 Thousand | -748.6 Thousand |
| Earnings before Tax | -3.41 Million | -4.45 Million | -8.94 Million | -7.24 Million | -6.74 Million | -7.95 Million |
| Net Income | -2.92 Million | -3.8 Million | -8.17 Million | -6.85 Million | -6.12 Million | -7.2 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | -0.05 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | -0.05 |
| Weighted Average Shares Outstanding | 360.71 Million | 302.91 Million | 251.16 Million | 200 Million | 153.45 Million | 138.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 362 Million | 302.91 Million | 251.16 Million | 200.17 Million | 153.45 Million | 138.83 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | -42.62 | -42.45 | -78.66 | -96.18 |
| Profit Margin | - | - | -69.07 | -54.16 | -78.58 | -88.66 |
| EBITDA | -3.02 Million | -2.91 Million | -8.7 Million | -6.84 Million | -6.65 Million | -7.81 Million |
| Earnings Before Tax Margin | - | - | -55.66 | -44.13 | -80.61 | -99.41 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | -34.98 Thousand | -34.98 Thousand | 69.95 Thousand |
| Cost of Revenue | 18.84 Thousand | - | 37.6 Thousand | - | - | 58.78 Thousand |
| Gross Profit | -18.84 Thousand | - | -37.6 Thousand | -34.98 Thousand | -34.98 Thousand | 11.17 Thousand |
| Operating Expenses | 382.11 Thousand | 382.11 Thousand | 3.14 Million | 847.31 Thousand | 1.02 Million | 1.3 Million |
| Selling, General and Administrative Expenses | 145.35 Thousand | 145.35 Thousand | - | 310.49 Thousand | 310.49 Thousand | 480.81 Thousand |
| Research and Development Expenses | 236.76 Thousand | 236.76 Thousand | - | 596.76 Thousand | 596.76 Thousand | 828.76 Thousand |
| Other Expenses | - | - | - | -59.94 Thousand | - | - |
| Cost and Expenses | 382.11 Thousand | 382.11 Thousand | 3.18 Million | 847.31 Thousand | 1.02 Million | 1.36 Million |
| Operating Income | -382.11 Thousand | -382.11 Thousand | -3.18 Million | -882.29 Thousand | -882.29 Thousand | -1.29 Million |
| Interest Expense | - | - | 1986.00 | - | - | 931.00 |
| Income Tax Expense | 103.45 Thousand | 103.45 Thousand | -497.1 Thousand | 103.7 Thousand | 103.7 Thousand | -289.69 Thousand |
| Earnings before Tax | -297.38 Thousand | -297.38 Thousand | -3.41 Million | -1.14 Million | -1.14 Million | -1.13 Million |
| Net Income | -193.92 Thousand | -193.92 Thousand | -2.92 Million | -1.03 Million | -1.03 Million | -847.36 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 417.04 Million | 417.04 Million | 362 Million | 386.15 Million | 386.15 Million | 333.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 416.43 Million | 416.43 Million | 362 Million | 390.6 Million | 390.6 Million | 333.4 Million |
| Gross Margin | - | - | - | 1.00 | 1.00 | 0.16 |
| EBIT Margin | - | - | - | 24.95 | 24.76 | -17.72 |
| Profit Margin | - | - | - | 29.65 | 29.65 | -12.11 |
| EBITDA | -372.69 Thousand | -372.69 Thousand | - | -872.89 Thousand | -866.23 Thousand | -1.23 Million |
| Earnings Before Tax Margin | - | - | - | 25.22 | 25.22 | -18.56 |
ACO-Y
GAZP
1319
TGTX
VVY
MKC